Literature DB >> 18670025

Novel anti-adhesive pericardial substitute for multistage cardiac surgery.

Goki Matsumura1, Toshiharu Shin'oka, Yoshito Ikada, Takahiko Sakamoto, Hiromi Kurosawa.   

Abstract

Dense adhesions in the retrosternal space make reoperations difficult in the field of cardiovascular surgery. Several substitutes for pericardium have been employed to prevent dense adhesions forming, but they have been unsatisfactory because of peel formation, calcification, and infection. To overcome these drawbacks, a novel biodegradable pericardial substitute was developed from gelatin obtained from specific-pathogen-free porcine skin and a bioabsorbable polyester mesh, which persists while the adhesion reaction occurs in the retrosternal space. A clinical pilot study of this gelatin sheet was carried out in patients scheduled to receive multistage cardiac surgery. From February 2003 to July 2004, the material was used in 5 patients aged 0.4 to 3.0 years. There were no complications related to the gelatin sheet. The effectiveness of the material was evaluated when the sternum was reopened 1.4 +/- 0.5 years later. It took 24.5 +/- 6.0 min for the resternotomy, and all surgeons who participated in the surgery rated the effectiveness of the gelatin sheet as "good". This anti-adhesive sheet prevented dense adhesions, suggesting that this material may be useful as a pericardial substitute for multistage pediatric cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670025     DOI: 10.1177/021849230801600411

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

Review 1.  Biomaterials advances in patches for congenital heart defect repair.

Authors:  Seokwon Pok; Jeffrey G Jacot
Journal:  J Cardiovasc Transl Res       Date:  2011-06-07       Impact factor: 4.132

2.  Sterile Gelatin Film Reduces Cortical Injury Associated With Brain Tumor Re-Resection.

Authors:  Colin J Przybylowski; Veronica So; Kaylee DeTranaltes; Corey Walker; Jacob F Baranoski; Kristina Chapple; Nader Sanai
Journal:  Oper Neurosurg (Hagerstown)       Date:  2021-03-15       Impact factor: 2.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.